Specialized Medical Company vs HCA Healthcare, Inc.
A head-to-head of Specialized Medical Company (4019) and HCA Healthcare, Inc. (HCA) across valuation, profitability, growth, and dividends. Green marks the more favourable value on that metric only — not a recommendation.
| Metric | 4019 | HCA |
|---|---|---|
| Market Cap | 4.18B SAR | $82.34B |
| P/E (TTM) | 15.09 | 12.76 |
| Forward P/E | 15.21 | 13.11 |
| P/S | 2.70 | 1.26 |
| P/B | 3.93 | -16.19 |
| EV/EBITDA | 16.36 | 9.68 |
| Dividend Yield | 1.91% | 0.83% |
| Profit Margin | 17.36% | 8.89% |
| Gross Margin | 24.89% | 41.50% |
| Operating Margin | 15.82% | 15.83% |
| Revenue Growth (YoY) | +3.19% | +4.30% |
| FCF Yield | 4.78% | 8.22% |
| Debt / Equity | 52.90 | — |
| Current Ratio | 1.10 | 0.83 |
Which is better: Specialized Medical Company or HCA Healthcare, Inc.?
- ✓Larger by market cap: HCA Healthcare, Inc.
- ✓Cheaper valuation (lower P/E): HCA Healthcare, Inc.
- ✓Higher dividend yield: Specialized Medical Company
- ✓More profitable (net margin): Specialized Medical Company
- ✓Faster revenue growth: HCA Healthcare, Inc.
- ✓Higher free-cash-flow yield: HCA Healthcare, Inc.
Across 11 available metrics, HCA Healthcare, Inc. leads 8–3.
There's no single "better" — it depends on your goal: income investors may prefer the higher yield, growth investors the faster grower, and value investors the cheaper one. See each stock's page for deeper detail. This is an automated read, not a recommendation.
Share:
Compare Specialized Medical Company with others
This comparison is for informational and educational purposes only, based on available data — not a recommendation to buy or sell any stock.